We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
-4.35%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$1.3B
AUM Growth
+$7.71M
Cap. Flow
+$92.4M
Cap. Flow %
7.09%
Top 10 Hldgs %
6.04%
Holding
1,409
New
392
Increased
321
Reduced
279
Closed
417

Top Buys

Rank Stock Value
1
SYF icon
Synchrony
SYF
+$9.84M
2
LH icon
Labcorp
LH
+$8.89M
3
HUBB icon
Hubbell
HUBB
+$7.76M
4
SNY icon
Sanofi
SNY
+$7.7M
5
JHG
Janus Henderson
JHG
+$7.68M

Top Sells

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$10.4M
2
FAST icon
Fastenal
FAST
+$10.2M
3
HCA icon
HCA Healthcare
HCA
+$9.44M
4
SCHW
Charles Schwab
SCHW
+$9.09M
5
NVS icon
Novartis
NVS
+$9.01M

Sector Composition

Rank Sector Weight
1 Financials 17%
2 Healthcare 16.16%
3 Consumer Discretionary 11.61%
4 Industrials 11.13%
5 Technology 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MYGN icon
951
Myriad Genetics
MYGN
$309M
$188K 0.01%
21,190
-105,795
-83% -$1.27M
GPRK icon
952
GeoPark
GPRK
$602M
$186K 0.01%
23,075
-146,957
-86% -$1.32M
KC
953
Kingsoft Cloud Holdings
KC
$3.52B
$185K 0.01%
+12,873
New +$193K
BBDC icon
954
Barings BDC
BBDC
$966M
$183K 0.01%
+19,202
New +$189K
KRNY icon
955
Kearny Financial
KRNY
$600M
$181K 0.01%
+28,985
New +$198K
SLRC icon
956
SLR Investment Corp
SLRC
$700M
$179K 0.01%
10,638
-2,293
-18% -$39K
HCAT icon
957
Health Catalyst
HCAT
$135M
$178K 0.01%
39,243
-4,012
-9% -$21.2K
MXL icon
958
MaxLinear
MXL
$6.74B
$176K 0.01%
+16,223
New +$271K
CRMD icon
959
CorMedix
CRMD
$557M
$174K 0.01%
28,251
-33,101
-54% -$343K
ODP
960
DELISTED
ODP
ODP
$171K 0.01%
+11,940
New +$229K
HLX icon
961
Helix Energy Solutions
HLX
$1.49B
$171K 0.01%
+20,549
New +$173K
TFSL icon
962
TFS Financial
TFSL
$4.89B
$170K 0.01%
13,754
-12,015
-47% -$154K
BCRX icon
963
BioCryst Pharmaceuticals
BCRX
$2.71B
$163K 0.01%
+21,684
New +$175K
BMBL icon
964
Bumble
BMBL
$344M
$156K 0.01%
+35,908
New +$234K
RNW icon
965
ReNew
RNW
$2.48B
$150K 0.01%
25,464
-28,795
-53% -$186K
PKE icon
966
Park Aerospace
PKE
$828M
$140K 0.01%
10,373
-8,795
-46% -$124K
BWLP icon
967
BW LPG
BWLP
$3.36B
$139K 0.01%
12,862
-108,291
-89% -$1.29M
PCYO icon
968
Pure Cycle
PCYO
$273M
$139K 0.01%
13,260
+523
+4% +$5.94K
RPAY icon
969
Repay Holdings
RPAY
$311M
$138K 0.01%
24,754
-2,556
-9% -$17.6K
DAKT icon
970
Daktronics
DAKT
$997M
$135K 0.01%
+11,063
New +$167K
LUNG icon
971
Pulmonx
LUNG
$98.4M
$130K 0.01%
19,244
+6,186
+47% +$43.8K
NXE icon
972
NexGen Energy
NXE
$7.07B
$128K 0.01%
28,595
-10,909
-28% -$64.5K
GRFS
973
Grifois
GRFS
$5.4B
$126K 0.01%
+17,758
New +$134K
SRTS icon
974
Sensus Healthcare
SRTS
$51.5M
$126K 0.01%
26,548
-4,829
-15% -$28.1K
ARLO icon
975
Arlo Technologies
ARLO
$1.5B
$125K 0.01%
+12,698
New +$145K
37 38
39
40 41

Similar funds

BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.9B AUM 2.22% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return

Campbell & Co Investment Adviser's Q1 2025 Portfolio in Review

As of Q1 2025, Campbell & Co Investment Adviser held 1,409 positions worth $1.3B, up 0.6% from $1.3B the previous quarter. Its ten largest holdings account for 6% of the portfolio.

Campbell & Co Investment Adviser deployed $92.4M of net new capital in Q1 2025, opening 392 new positions and adding to 321 existing holdings. Its largest new stake was Synchrony: 159,080 shares worth $8.42M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Novartis, an estimated $9.01M trimmed.

  • Campbell & Co Investment Adviser's largest Q1 2025 buy was Synchrony: 159,080 shares worth $8.42M.
  • Campbell & Co Investment Adviser added most to Labcorp in Q1 2025, an estimated $8.89M increase.
  • Campbell & Co Investment Adviser's biggest Q1 2025 reduction was Novartis, cutting an estimated $9.01M.
  • Campbell & Co Investment Adviser fully exited Intercontinental Exchange in Q1 2025, selling an estimated $10.4M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 6% of its $1.3B portfolio in Q1 2025.
  • Campbell & Co Investment Adviser opened 392 new positions and closed 417 in Q1 2025.
  • Campbell & Co Investment Adviser's portfolio value rose 0.6% quarter-over-quarter to $1.3B.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2025, filed 14 May 2025.